Johnson & Johnson logo

JNJ - Johnson & Johnson Share Price

$149.17 1.0  0.7%

Last Trade - 17/01/20

Sector
Healthcare
Size
Large Cap
Market Cap £301.81bn
Enterprise Value £310.09bn
Revenue £63.07bn
Position in Universe 14th / 6410
Bullish
Bearish
Unlock JNJ Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

JNJ Revenue Unlock JNJ Revenue

Net Income

JNJ Net Income Unlock JNJ Revenue

Normalised EPS

JNJ Normalised EPS Unlock JNJ Revenue

PE Ratio Range

JNJ PE Ratio Range Unlock JNJ Revenue

Dividend Yield Range

JNJ Dividend Yield Range Unlock JNJ Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
JNJ EPS Forecasts Unlock JNJ Revenue
Profile Summary

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Directors
Last Annual December 30th, 2018
Last Interim September 30th, 2019
Incorporated November 10, 1887
Public Since September 25, 1944
No. of Shareholders: 142,029
No. of Employees: 135,100
Sector Healthcare
Industry Pharmaceuticals
Index Dow Jones Composite , Dow Jones Industrial Average , FTSE Global 100, S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 2,631,872,399
Free Float (0.0%)
Eligible for
ISAs
SIPPs
JNJ Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for JNJ
Upcoming Events for JNJ
Similar to JNJ
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.